UK Markets open in 14 mins

Velocys plc (VLS.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
5.50-0.22 (-3.76%)
At close: 4:35PM BST
Full screen
Previous close5.72
Open5.91
Bid5.52 x 0
Ask5.58 x 0
Day's range5.50 - 5.97
52-week range4.51 - 15.61
Volume921,611
Avg. volume2,686,666
Market cap58.551M
Beta (5Y monthly)1.49
PE ratio (TTM)N/A
EPS (TTM)-1.30
Earnings date02 Aug 2021 - 06 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est26.65
  • Business Wire

    Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

    Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the quarter ended March 31, 2021 with the Securities and Exchange Commission ("SEC") on Wednesday, May 12, 2021.

  • Business Wire

    Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results

    Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the Securities and Exchange Commission ("SEC") on Tuesday, March 30, 2021.

  • Business Wire

    Fuse Medical, Inc. Announces Exclusive Agreement With Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum™ Staple System

    Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with Orthovestments, LLC for the exclusive manufacturing and commercialization of the Orbitum™ Staple System ("OrbitumTM") for the US market. This is the latest addition to Fuse’s comprehensive orthopedic portfolio of internal fixation devices for upper and lower extremities. Initial launch of the Orbitum™ is anticipated for the beginning of the second quarter of 2021.